These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22393119)

  • 41. Acute coronary syndrome after levamisole-adultered cocaine abuse.
    Michaud K; Grabherr S; Shiferaw K; Doenz F; Augsburger M; Mangin P
    J Forensic Leg Med; 2014 Jan; 21():48-52. PubMed ID: 24365689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levamisole toxicity.
    Graebner RW
    Mayo Clin Proc; 2012 Oct; 87(10):1033-4; author reply 1034. PubMed ID: 23036678
    [No Abstract]   [Full Text] [Related]  

  • 43. Bioanalytical methods for quantitation of levamisole, a widespread cocaine adulterant.
    Shea JL
    Clin Chem Lab Med; 2013 Jan; 51(1):205-12. PubMed ID: 23152411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding.
    Jacob RS; Silva CY; Powers JG; Schieke SM; Mendese G; Burlingame RW; Miller DD; Wolpowitz D; Graber E; Mahalingam M
    Am J Dermatopathol; 2012 Apr; 34(2):208-13. PubMed ID: 22094232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levamisole-adulterated cocaine: a case series.
    Morris GW; Mason BC; Harris Sprunger R; Hake Harris H; White LA; Patterson DA
    J Am Board Fam Med; 2012; 25(4):531-5. PubMed ID: 22773722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aminorex, a metabolite of the cocaine adulterant levamisole, exerts amphetamine like actions at monoamine transporters.
    Hofmaier T; Luf A; Seddik A; Stockner T; Holy M; Freissmuth M; Ecker GF; Schmid R; Sitte HH; Kudlacek O
    Neurochem Int; 2014 Jul; 73(100):32-41. PubMed ID: 24296074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small vessel vasculitis associated with cocaine use.
    Rietkerk W; Pereira F; Poste J
    Cutis; 2013 Jan; 91(1):21-4. PubMed ID: 23461054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cocaine/levamisole-associated autoimmune syndrome: a disease of neutrophil-mediated autoimmunity.
    Cascio MJ; Jen KY
    Curr Opin Hematol; 2018 Jan; 25(1):29-36. PubMed ID: 29211697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extensive Necrotic Purpura in Levamisole-Adulterated Cocaine Abuse - A Case Report.
    Le Garff E; Tournel G; Becquart C; Cottencin O; Dupin N; Delaporte E; Hedouin V
    J Forensic Sci; 2016 Nov; 61(6):1681-1685. PubMed ID: 27500987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Agranulocytosis in cocaine users in Ohio: suspected levamisole taint.
    Herms B; Kaplon M; Baumann M
    Leuk Res; 2011 Sep; 35(9):e173-4. PubMed ID: 21641036
    [No Abstract]   [Full Text] [Related]  

  • 51. Vasculopathy related to cocaine adulterated with levamisole: A review of the literature.
    Pearson T; Bremmer M; Cohen J; Driscoll M
    Dermatol Online J; 2012 Jul; 18(7):1. PubMed ID: 22863623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review.
    Midthun KM; Nelson LS; Logan BK
    Ther Drug Monit; 2021 Apr; 43(2):221-228. PubMed ID: 33298746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levamisole in Illicit Trafficking Cocaine Seized: A One-Year Study.
    Martello S; Pieri M; Ialongo C; Pignalosa S; Noce G; Vernich F; Russo C; Mineo F; Bernardini S; Marsella LT
    J Psychoactive Drugs; 2017; 49(5):408-412. PubMed ID: 28813206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agranulocytosis - Sequelae of Chronic Cocaine Use: Case Series and Literature Review.
    Srivastava R; Rizwan M; Jamil MO; Kogulan P; Salzman D
    Cureus; 2017 May; 9(5):e1221. PubMed ID: 28589070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purpura, cutaneous necrosis, and antineutrophil cytoplasmic antibodies associated with levamisole-adulterated cocaine.
    Graf J; Lynch K; Yeh CL; Tarter L; Richman N; Nguyen T; Kral A; Dominy S; Imboden J
    Arthritis Rheum; 2011 Dec; 63(12):3998-4001. PubMed ID: 22127712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole.
    Mielants H; Veys EM
    Acta Rhumatol Belg; 1979; 3(2):104-9. PubMed ID: 546061
    [No Abstract]   [Full Text] [Related]  

  • 57. [Granulocytotoxic antibodies in levamisole-induced agranulocytosis].
    Rosenthal M
    Klin Wochenschr; 1982 Oct; 60(20):1297-302. PubMed ID: 7144065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse reactions to levamisole.
    Symoens J; Veys E; Mielants M; Pinals R
    Cancer Treat Rep; 1978 Nov; 62(11):1721-30. PubMed ID: 365327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital.
    Buchanan JA; Heard K; Burbach C; Wilson ML; Dart R
    JAMA; 2011 Apr; 305(16):1657-8. PubMed ID: 21521846
    [No Abstract]   [Full Text] [Related]  

  • 60. Agranulocytosis in an arthritic patient treated with levamisole. A case report.
    du P Heyns A; Retief FP; Vorster BJ
    S Afr Med J; 1979 Feb; 55(5):177-9. PubMed ID: 424968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.